Kit A. Keller

Targeting hepatic glucokinase to treat diabetes with TTP399, a hepatoselective glucokinase activator

Adrian Vella, Jennifer L. R. Freeman, Imogene Dunn et al. · Science Translational Medicine · 2019 · 78 citations

Medicine, Biochemistry, Pharmacology +15

Mice exposed in utero to low concentrations of benzene exhibit enduring changes in their colony forming hematopoietic cells

Kit A. Keller · Toxicology · 1986 · 44 citations

Pharmacy, Hematology, Toxicology +16

Mice exposed in utero to 20 ppm benzene exhibit altered numbers of recognizable hematopoietic cells up to seven weeks after exposure

Kit A. Keller · Fundamental and Applied Toxicology · 1988 · 43 citations

Pharmacy, Hematology, Toxicology +14

Embryotoxicity of cisplatin in rats and mice

Kit A. Keller, Shruti Aggarwal · Toxicology and Applied Pharmacology · 1983 · 38 citations

Pharmacy, Oncology, Toxicology +9

From Committees of RUSA: Meeting the Need for Library-based Financial Literacy Education

Kit A. Keller, Chris LeBeau, Elizabeth Malafi et al. · Reference & User Services Quarterly · 2015 · 13 citations · Full text

Education, Finance, Literacy Education +10